Larson Financial Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Larson Financial Group's AXSM Position: Q3 2026 in Review
Larson Financial Group reduced its Axsome Therapeutics (AXSM) stake by 5.6% in Q3 2026, selling an estimated $870 and leaving 68 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2396.
Larson Financial Group first reported a position in AXSM in Q1 2025 and has held it in 7 quarters since. The position peaked at $17.6K in Q2 2026. 465 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Larson Financial Group held 68 shares of Axsome Therapeutics worth $12.5K as of Q3 2026.
- Larson Financial Group sold 4 Axsome Therapeutics shares in Q3 2026, an estimated $870.
- Axsome Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2396 holding.
- Larson Financial Group first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 7 quarters since.
- Larson Financial Group's Axsome Therapeutics position peaked at $17.6K in Q2 2026.
- 465 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.